All results
9 results
-
APL2-C3G-310
This is a Phase 3 study to assess the efficacy and safety of twice-weekly subcutaneous (SC) doses of pegcetacoplan compared to placebo in patients with C3…
- Ages
- 12 Years - N/A
- Sexes
- All
-
APL2-C3G-314
This study is designed as a long-term extension to Study APL2-C3G-310, and is being conducted to establish the long-term safety and efficacy of pegcetacoplan…
- Ages
- 12 Years - N/A
- Sexes
- All
-
GSK Nimble
This study will assess whether switching participants who have benefitted from mepolizumab or benralizumab to GSK3511294 (Depemokimab) is non-inferior to…
- Ages
- 12 Years - N/A
- Sexes
- All
-
Meteoroid
The main objective of the study is to evaluate the efficacy of satralizumab compared with placebo based on time from randomization to the first occurrence of…
- Ages
- 12 Years - N/A
- Sexes
- All
-
Mino-Lok
This is a Phase 3, multi-center, randomized, open-label, assess-blind study to determine the efficacy and safety of MLT, a novel antibiotic lock therapy that…
- Ages
- 12 Years - N/A
- Sexes
- All
-
NIMBLE
This study will assess whether switching participants who have benefitted from mepolizumab or benralizumab to GSK3511294 (Depemokimab) is non-inferior to…
- Ages
- 12 Years - N/A
- Sexes
- All
-
RAISE
This study will evaluate the effectiveness and safety of an investigational product (IP), intravenous (IV) ganaxolone, to treat participants with status…
- Ages
- 12 Years - N/A
- Sexes
- All
-
Recursion 201
This is a two-staged, Phase 2/3, randomized, multi-center study to investigate the efficacy and safety of REC-2282 in patients with progressive NF2 mutated…
- Ages
- 12 Years - N/A
- Sexes
- All
-
TAPUR: Testing FDA Approved Drugs That Target Specific Abnormal Tumor Genes in Pts w/Advanced Cancer
The purpose of the study is to learn from the real world practice of prescribing targeted therapies to patients with advanced cancer whose tumor harbors a…
- Ages
- 12 Years - N/A
- Sexes
- All